These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26810447)

  • 1. Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis.
    Xu LY; Zhang WM; Xia M; Cao LF
    Pediatr Neonatol; 2016 Oct; 57(5):396-401. PubMed ID: 26810447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extracellular histones in systemic-onset juvenile idiopathic arthritis.
    Hu X; Xie Q; Mo X; Jin Y
    Ital J Pediatr; 2019 Jan; 45(1):14. PubMed ID: 30642364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of Th1/Th2 cytokines in children with non-systemic juvenile idiopathic arthritis].
    Lijiao J; Meiping LU; Li G; Jianqiang WU; Lixia Z; Yiping XU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):281-6. PubMed ID: 27651193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis].
    Zhou YF; Li CF; Wang J; Han TX; Kuang WY; Deng JH; Zhang JM; Tan XH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2487-9. PubMed ID: 24300271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.
    Feng M; Kang M; He F; Xiao Z; Liu Z; Yao H; Wu J
    J Transl Med; 2018 Oct; 16(1):277. PubMed ID: 30305171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.
    Pascual V; Allantaz F; Arce E; Punaro M; Banchereau J
    J Exp Med; 2005 May; 201(9):1479-86. PubMed ID: 15851489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum cytokine levels in children with newly diagnosed active systemic juvenile idiopathic arthritis].
    Guo L; Lu MP; Tang YM; Teng LP; Xu YP; Zou LX; Zheng RJ; Zheng Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1241-4. PubMed ID: 25523573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juvenile Idiopathic Arthritis Patients.
    Peng Y; Liu X; Duan Z; Duan J; Zhou Y
    Mediators Inflamm; 2021; 2021():6650928. PubMed ID: 33824623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
    Jin YJ; Sun L; Yang L; Xing R; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of interleukin-6, interferon-inducible protein-10 and interleukin-17 in serum and synovial fluid of patients with juvenile idiopathic arthritis].
    Li RJ; Tang XM; Liu W; Zhou J; An YF; Qin SY; Zou ZY
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):472-6. PubMed ID: 24120067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.
    de Benedetti F; Massa M; Robbioni P; Ravelli A; Burgio GR; Martini A
    Arthritis Rheum; 1991 Sep; 34(9):1158-63. PubMed ID: 1930333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity.
    Cantarini L; Simonini G; Fioravanti A; Generoso M; Bacarelli MR; Dini E; Galeazzi M; Cimaz R
    Clin Exp Rheumatol; 2011; 29(6):1044-8. PubMed ID: 22032341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome.
    Zhang WM; Xu LY; Lu YM; Cao LF
    Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):176-81. PubMed ID: 24611751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).
    Hedrich CM; Bruck N; Fiebig B; Gahr M
    Rheumatol Int; 2012 Nov; 32(11):3525-30. PubMed ID: 22083619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis.
    Lepore L; Pennesi M; Saletta S; Perticarari S; Presani G; Prodan M
    Clin Exp Rheumatol; 1994; 12(5):561-5. PubMed ID: 7531125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA).
    Möller JC; Paul D; Ganser G; Range U; Gahr M; Kelsch R; Rösen-Wolff A; Hedrich CM
    Clin Exp Rheumatol; 2010; 28(6):912-8. PubMed ID: 21205466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.